Global HLA Typing for Transplant Industry (2019 to 2025) - Increasing Number of Transplant Procedures Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "HLA Typing for Transplant Market by Technology (PCR (SSO, SSP, Real Time), Sequencing (NGS, Sanger)), Product (Instrument, Reagent, Software), Application (Chimerism, Antibody Screening), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%.

The demand for HLA typing products for transplant is expected to grow due to technological advancements in the field of HLA typing and increasing public-private funding for target research activities. the HLA typing for the transplants market is segmented on the product, technology, application, end-user, and region.

The independent reference laboratories segment accounted for the largest share of the HLA typing for transplants market, by end-user, in 2019.

Based on end-user, the HLA typing for transplants market is segmented into independent reference laboratories, hospitals & transplant centres, and research laboratories & academic institutes. in 2019, independent reference laboratories accounted for the largest share of the HLA typing for transplants market due to rapid modernization and automation in diagnostic laboratories, the growing number of R&D activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.

The molecular assay technologies segment accounted for the largest share of the HLA typing for transplants market, by technology, in 2019.

The HLA typing for transplants market, by technology, is segmented into molecular (PCR-based assay and sequencing-based assay technologies) and non-molecular assay technologies. in 2019, the molecular assay technologies segment accounted for the largest share of the HLA typing for transplants market due to the benefits of molecular assays such as low turnaround times, high procedural efficacy, and real-time sample analysis.

North America accounted for the largest share of the HLA typing for transplants market in 2019.

North America accounted for the largest share of the HLA typing for transplants market in 2019, followed by Europe. This can primarily be attributed to the wide availability of advanced transplant diagnostic technologies (includes HLA typing), well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for donors and recipients during transplantations.

Market Dynamics

Drivers

• Increasing Number of Transplant Procedures
• Technological Advancements in the Field of HLA Typing
• Increasing Public-Private Funding for Target Research Activities

Restraints

• High Costs of Molecular Tests Used for HLA Typing Procedures
• Limited Reimbursements for Target Procedures

Opportunities

• Rising Adoption of Cross-Matching and Chimerism Testing during Pre- & Post-Transplantation
• Technological Shift from Non-Molecular Serological Assays to Gene-Based HLA Profiling
• Increasing Public Awareness About Organ Donation and Transplantation Across Emerging Countries

Challenges

• Significant Gap Between the Number of Organ Donors and Organs Required Annually

Companies Profiled

• Thermo Fisher Scientific
• F. Hoffman-La Roche Limited
• Qiagen
• Immucor
• Abbott Laboratories Inc.
• Caredx, Inc.
• Illumina
• Bio-Rad Laboratories
• Alpha Biotech, Ltd.
• Gendx
• Luminex
• Biofortuna
• Omixon
• Creative Biolabs
• Tbg Diagnostics Limited
• Bag Healthcare
• Takara Bio
• Histogenetics Llc
• Pacific Biosciences of California, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/46jsky